News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,553 Results
Type
Article (4722)
Company Profile (5)
Press Release (99826)
Multimedia
Podcasts (19)
Webinars (5)
Section
Business (29837)
Career Advice (33)
Deals (5908)
Drug Delivery (6)
Drug Development (13163)
Employer Resources (15)
FDA (3389)
Job Trends (1653)
News (53002)
Policy (4874)
Tag
Academia (238)
Accelerated approval (7)
Adcomms (3)
Allergies (19)
Alliances (9810)
ALS (38)
Alzheimer's disease (547)
Antibody-drug conjugate (ADC) (95)
Approvals (3542)
Artificial intelligence (41)
Autoimmune disease (40)
Automation (1)
Bankruptcy (16)
Best Places to Work (1266)
Biosimilars (90)
Biotechnology (7)
Bladder cancer (38)
Brain cancer (9)
Breast cancer (75)
Cancer (727)
Cardiovascular disease (100)
Career advice (37)
Career pathing (1)
CAR-T (13)
CDC (2)
Cell therapy (84)
Cervical cancer (5)
Clinical research (11747)
Collaboration (365)
Compensation (36)
Complete response letters (13)
COVID-19 (289)
CRISPR (9)
C-suite (150)
Cystic fibrosis (9)
Data (1152)
Depression (29)
Dermatology (14)
Diabetes (73)
Diagnostics (815)
Digital health (8)
Diversity, equity & inclusion (4)
Drug discovery (47)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (50)
Earnings (11529)
Editorial (8)
Employer branding (8)
Employer resources (15)
Events (11849)
Executive appointments (137)
FDA (4074)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (201)
Gene editing (18)
Generative AI (1)
Gene therapy (61)
GLP-1 (120)
Government (390)
Grass and pollen (1)
Guidances (59)
Healthcare (1801)
HIV (5)
Huntington's disease (7)
IgA nephropathy (26)
Immunology and inflammation (28)
Immuno-oncology (10)
Indications (30)
Infectious disease (318)
Inflammatory bowel disease (28)
Inflation Reduction Act (2)
Influenza (14)
Intellectual property (49)
Interviews (1)
IPO (2086)
Job creations (441)
Job search strategy (34)
JPM (15)
Kidney cancer (2)
Labor market (2)
Layoffs (43)
Leadership (3)
Legal (1223)
Liver cancer (29)
Longevity (3)
Lung cancer (127)
Lymphoma (45)
Machine learning (2)
Management (3)
Manufacturing (139)
MASH (28)
Medical device (2750)
Medtech (2772)
Mergers & acquisitions (4048)
Metabolic disorders (164)
mRNA (18)
Multiple sclerosis (31)
NASH (3)
Neurodegenerative disease (102)
Neuropsychiatric disorders (20)
Neuroscience (780)
Neurotech (1)
NextGen: Class of 2026 (498)
Non-profit (223)
Obesity (51)
Opinion (35)
Ovarian cancer (33)
Pain (28)
Pancreatic cancer (31)
Parkinson's disease (56)
Partnered (6)
Patents (97)
Patient recruitment (104)
Peanut (1)
People (8277)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (3138)
Phase 2 (5056)
Phase 3 (4488)
Pipeline (1389)
Policy (16)
Postmarket research (475)
Preclinical (1162)
Press Release (2)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (28)
Rare diseases (142)
Real estate (799)
Recruiting (4)
Regulatory (4156)
Reports (7)
Research institute (217)
Rett syndrome (1)
RNA editing (2)
RSV (4)
Schizophrenia (27)
Series A (42)
Series B (32)
Service/supplier (1)
Sickle cell disease (14)
Special edition (4)
Spinal muscular atrophy (80)
Sponsored (1)
Startups (633)
Stomach cancer (2)
Supply chain (14)
Tariffs (4)
The Weekly (19)
Vaccines (60)
Venture capital (8)
Weight loss (22)
Women's health (8)
Date
Today (25)
Last 7 days (109)
Last 30 days (380)
Last 365 days (4240)
2026 (1491)
2025 (4208)
2024 (4778)
2023 (5546)
2022 (9279)
2021 (8684)
2020 (7898)
2019 (5654)
2018 (4464)
2017 (5195)
2016 (4712)
2015 (5927)
2014 (4467)
2013 (3717)
2012 (3911)
2011 (4096)
2010 (3831)
Location
Africa (123)
Alabama (7)
Arizona (33)
Arkansas (1)
Asia (23148)
Australia (2678)
California (1279)
Canada (600)
China (470)
Colorado (19)
Connecticut (32)
Delaware (31)
Europe (16764)
Florida (214)
Georgia (36)
Idaho (1)
Illinois (73)
India (47)
Indiana (24)
Japan (308)
Kansas (15)
Kentucky (1)
Louisiana (3)
Maine (5)
Maryland (157)
Massachusetts (1096)
Michigan (22)
Minnesota (129)
Mississippi (1)
Missouri (15)
Nebraska (3)
Nevada (19)
New Hampshire (8)
New Jersey (664)
New Mexico (2)
New York (404)
North Carolina (245)
Northern California (651)
Ohio (21)
Oklahoma (1)
Oregon (3)
Pennsylvania (228)
Puerto Rico (4)
Rhode Island (2)
South America (153)
South Carolina (9)
Southern California (470)
Tennessee (7)
Texas (125)
United States (4954)
Utah (43)
Virginia (58)
Washington D.C. (5)
Washington State (80)
West Virginia (2)
Wisconsin (7)
104,553 Results for "vascular biogenics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
Biogen ready to catch Alzheimer’s patients transitioning off Lilly’s Kisunla
Key dosing differences between Eli Lilly’s Kisunla and Biogen’s Leqembi are about to come to a head in the Alzheimer’s market as patients end their 18-month course of Lilly’s product.
April 29, 2026
·
3 min read
·
Annalee Armstrong
Earnings
With growth curve trending up, Biogen looks to early-stage assets for ‘next generation’
Biogen’s growth was expected to stay flat through the 2030s. A key acquisition and busy late-stage pipeline have relieved the pressure and cleared the way for some early-stage bets, CEO Chris Viehbacher said Wednesday.
April 29, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth.
February 6, 2026
·
2 min read
·
Annalee Armstrong
Alzheimer’s disease
Biogen’s Much Anticipated Tau Readout in Alzheimer’s Will Spur More Questions
Analysts, investors and scientists are eager for Biogen’s 2026 BIIB080 readout. Even if successful, executives warn that there are many more steps before the Alzheimer’s therapy could reach the market.
February 9, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy
In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the pharma’s own kidney disease asset, currently in multiple Phase 3 trials.
March 31, 2026
·
4 min read
·
Annalee Armstrong
Immunology and Inflammation
Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline
William Blair hailed a positive readout in cutaneous lupus erythematosus as a turning point for Biogen, while RBC Capital analysts called the results “another derisking step” for the company’s immunology and inflammation pipeline.
March 30, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
April 13, 2026
·
2 min read
Press Releases
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
April 16, 2026
·
6 min read
Press Releases
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
April 3, 2026
·
6 min read
Press Releases
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
May 5, 2026
·
4 min read
1 of 10,456
Next
